Federal Court Protects Alimta Against Generic Competitor

CPSM — Tue, 28 Dec 2010 17:26:23 +0000

Eli Lilly & Co. has won its case in Federal court in Delaware where it sought to protect its patent for the drug Alimta. Alimta (pemetrexed for injection) now marketed by Eli Lilly & Co. (“Lilly”) was developed in clinical trials by Lilly in the early 1990s after it was discovered that disodium pemetrexed, the [...]

Federal Court Protects Alimta Against Generic Competitor is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Front and Second Line Treatments for Mesothelioma

CPSM — Sun, 07 Feb 2010 22:06:16 +0000

If you or someone you know has been diagnosed with malignant mesothelioma, you are probably trying to understand which treatments might be most effective. If you have gone through initial treatment with little results, you may be exploring what other options you have. Recently medical researchers published an article in Cancer Treatment Reviews (February 2010) with a [...]

Front and Second Line Treatments for Mesothelioma is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Mesothelioma Blog » Pemetrexed

Federal Court Protects Alimta Against Generic Competitor

Front and Second Line Treatments for Mesothelioma